Global Blood Therapeutics Stock Price

Find the latest Global Blood Therapeutics Inc. 23 rows Lowest.

Gbt Global Blood Therapeutics Stock Price

The average price target includes all analyst.

Global blood therapeutics stock price. Quarterly Results Earnings per share were up 3711 over the past year to 100. The firm currently has a buy rating on the stock. Since then GBT stock has decreased by 355 and is now trading at 3538.

The average price target is 9032 with a high forecast of 15200 and a low forecast of 4500. View daily weekly or monthly. The company offers Oxbryta tablets an oral once-daily therapy for sickle cell disease SCD.

31 2020 at 804 am. This price target is based on 19 analysts offering 12 month price targets for Global Blood Therapeutics in the last 3 months. ET by Tomi Kilgore Global Blood Therapeutics downgraded to hold from buy at SunTrust RH.

They currently have a hold rating on the stock. And 431900 USD for 2026 May 08 Friday with technical analysis. 102 rows Discover historical prices for GBT stock on Yahoo Finance.

The Global Blood Therapeutics stock forecast is 95058107 USD for 2022 May 08 Sunday. GBT stock price news historical charts analyst ratings and financial information from WSJ. Global Blood Therapeutics stock price target cut to 75 from 110 at SunTrust RH Jan.

GBT stock quote history news and other vital information to help you with your stock trading and investing. Global Blood Therapeutics Inc a biopharmaceutical company engages in the discovery development and delivery of treatments for underserved patient communities. Shares of Global Blood Therapeutics NASDAQGBT decreased in after-market trading after the company reported Q4 results.

Global Blood Therapeutics GBT stock price prediction is 95058107 USD. Barrons also provides information on historical stock ratings target prices company earnings market. 124 350 DATA AS.

Several other equities research analysts also recently commented on the company. May 13 2021 400 PM EDT. Roth Capitals price objective indicates a potential upside of 22813 from the stocks previous close.

Data is currently not available. GBTNASDAQ GS Stock Quote - Global Blood Therapeutics Inc - Bloomberg Markets. View todays stock price news and analysis for Global Blood Therapeutics Inc.

Zacks Investment Research upgraded Global Blood Therapeutics from a sell rating. Global Blood Therapeutics Inc. Global Blood Therapeutics Inc.

The average price target represents a 10801 upside from the last price of 4342. Global Blood Therapeutics NASDAQGBT had its target price reduced by Canaccord Genuity from 4500 to 4000 in a report issued on Wednesday Benzinga reports. View the latest Global Blood Therapeutics Inc.

Global Blood Therapeutics stock was trading at 5485 on March 11th 2020 when Coronavirus COVID-19 reached pandemic status according to the World Health Organization WHO. Global Blood Therapeutics NASDAQGBT had its target price lowered by equities researchers at Roth Capital from 12800 to 12400 in a research report issued to clients and investors on Wednesday Benzinga reports. Real time Global Blood Therapeutics GBT stock price quote stock graph news analysis.

View which stocks have been most impacted by COVID-19.

Gbt Stock Price And Chart Nasdaq Gbt Tradingview

Eyeing These Global Therapeutics Stock Nasdaq Gbt Price Developments

Will Global Blood Therapeutics Gbt Report Negative Q1 Earnings What You Should Know Nasdaq

Global Blood Therapeutics Inc Nasdaq Gbt Analysts Are Cutting Their Estimates Here S What You Need To Know

Global Blood Therapeutics Stock Nasdaq Gbt Breaks Out Here Are The Implications

Eyeing These Global Therapeutics Stock Nasdaq Gbt Price Developments

Global Blood Therapeutics Stock Sell Off Alters My Investment Strategy Gbt Seeking Alpha

Global Blood Therapeutics Can This Biotech Still Disrupt The Sickle Cell Disease Space

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc

Technical Analysis Global Blood Therapeutics Stock Nasdaq Gbt Chart Is A Must See

Global Blood Therapeutics Oxbryta Is Aimed For Success Nasdaq Gbt Seeking Alpha

Gbt Institutional Ownership Global Blood Therapeutics Inc

Is Global Blood Therapeutics Nasdaq Gbt A Risky Investment

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc

Gbt Stock Price And Chart Nasdaq Gbt Tradingview

Gbt Stock Must Maintain Current Level Of Price Support

Global Blood Therapeutics Gbt Market Capitalization

Global Blood Therapeutics Share Price Gbt Stock Quote Charts Trade History Share Chat Financials Global Blood Therapeutics Inc

Global Blood Therapeutics Investment Risk Diminishing As Oxbryta Outperforms Nasdaq Gbt Seeking Alpha